knowledge -WSS

knowledge

author：explore 2025-09-30 21:57:29 - browse：6878

Gavel and Stethoscope due process — District courts will make the first round of decisions soon on challenges to Medicare's drug price negotiation program. APStock

WASHINGTON — Pharmaceutical companies’ efforts to scuttle President Biden’s signature health care achievement, empowering Medicare to negotiate prescription drug prices, will soon face their first big tests.

District court judges could soon weigh in on the litany of court cases that major companies filed against the government — shedding light on whether drugmakers have any hope of postponing the first parts of the negotiation process, scrapping it entirely, or sending the issue up to the Supreme Court.

It’s a major moment for the Biden administration, too, as the White House ramps up its efforts to take credit for the new changes in the 2024 election. The first round of legal decisions will play out in the thick of campaign season, attorneys told STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： New CMS data security rules will hurt Medicare, Medicaid research

focus

WSS

Congress may force more Covid

Cancer researcher Catriona Jamieson is sending tumors into space

H5N1 bird flu virus started spreading in cows in Texas in December

Cholera vaccine supply gets boost as demand surges globally

Element Biosciences CEO lays out genome sequencing strategy

Secretariat’s lessons for human medicine

hotspot

knowledge

explore

What does generative AI mean for health care? We asked experts

Researchers tackle phage therapy hurdles for wider adoption

Medical records are filled with copy

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

Apple is now the first public company to be valued at $3 trillion

Abridge raises $150m as clinical notes automation market heats up

New air purifier tech could be key to improving indoor air quality

In 'major milestone,' FDA approves first cell therapy for solid tumors

Cancer drug shortages should be causing more outrage

Cholera vaccine supply gets boost as demand surges globally

explore

Bird flu outbreak in cows is latest avian flu curveball

Obamacare plans could cover weight loss drugs

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Why does health care cost so much? A reading guide

Why rehabilitation engineers need to center patients in their research

Close Medicare's dangerous gaps in addiction treatment coverage

Wikipedia

focus

focus

leisure time